Market Overview

Morgan Stanley Reiterates Equal-Weight Rating on The Clorox Company on Strong Q2 EPS

Related CLX
Clorox Didn't 'Crash And Burn,' But Goldman Sachs Stays Neutral
Keep an Eye on These 15 Stocks for August 3, 2016

In a report published Monday, Morgan Stanley reiterated its Equal-Weight rating on The Clorox Company (NYSE: CLX).

Morgan Stanley noted, “Clorox 2Q EPS of $0.93 ($0.90 ex-item) were well ahead of the $0.81 consensus. Q2 was above consensus across the board with 4% revenue, 5% gross profit, and +12% operating profit upside vs. the Street. The quarter did benefit from shipments coming in ahead of underlying demand in bleach, an extra day, and lower A&P than we expected, but still produced solid upside vs. consensus ex these factors. Organic sales growth of ~5.5% (ex-extra selling day) came in ahead of the Street at +LSD, driven by ~2% pricing and ~3.5% volume (ex-extra selling day). FY guidance was only raised by 5 cents on the low-end, with VZ devaluation risk raised to 5-10 cents from 5 cents, and CLX management typically conservative, but a solid Q2 beat should be well received today.”

The Clorox Company closed on Friday at $79.16.

Latest Ratings for CLX

Aug 2016CitigroupMaintainsNeutral
Aug 2016UBSMaintainsSell
Jul 2016Deutsche BankMaintainsHold

View More Analyst Ratings for CLX
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Reiteration Analyst Ratings


Related Articles (CLX)

View Comments and Join the Discussion!